Peer-to-peer programs bring together clinical experts from the same field to share information and expertise on a specific pharma subject. Lately, there has emerged a high demand for clinically experienced doctors and experts to discuss with their peers and give advice to each other. In this episode of Pharma Launch Secrets, Bozidar is joined by Andrew Willmer, EVP of Strategy and Innovation at Symbiotix.